Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Pediatr. 2019 Sep 24;215:107–117.e12. doi: 10.1016/j.jpeds.2019.07.064

Figure 4 online:

Figure 4 online:

Plasma protein carbonyl concentration. A) The plasma protein carbonyl concentration (median and IQR) is are shown for samples acquired prior to IVIG administration (baseline) and after two weeks of atorvastatin compared with samples from matched KD control (ctl) patients B) The difference in plasma protein carbonyl concentration (baseline minus 2 week) for study subjects and matched control KD patients (median and IQR).